Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/b328f7b0-622f-41d7-b300-547319421bf9/

AVR

Anteris Technologies Global Corp.
Chart
13.80 AUD
Latest Week 2026-06-05
HealthcareMedical DevicesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh

Factors computed — awaiting universe ranking

✓
Fundamentals
✓
Snapshot
✓
Factors
…
Ranked
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
OS
Composite & Factor Heatmap
All factors at a glance
None
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
P/B z-score
-0.19
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
BDX BCAL Diagnostics Limited — — — —
BGT Bio-Gene Technology Limited — — — —
BB1 BLINKLAB FPO [BB1] — — — —
AYA Artrya Limited — — — —
ACL Australian Clinical Labs Limited — — — —
ACR Acrux Limited — — — —
ACW Actinogen Medical Limited — — — —
ADR Adherium Limited — — — —
Factor Interactions
Volatility Expanding
60-day vol (200%) significantly exceeds 252-day (85%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
10.6% avg (4 factors)
Quality
F
25.0% avg (7 factors)
Momentum
B
74.5% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
725.73
Price / Book
4.82
FCF Yield
-8.2%
Sales Yield (1/P·S)
0.0017
Shareholder Yield
Div + net buyback / mktcap
-24.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-34.2%
Return on Assets
-32.3%
Net Margin
-5148.8%
Operating Margin
-5206.0%
Gross Profit / Assets
Novy-Marx GPA
0.5%
Current Ratio
20.93
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.035
MomentumPrice trend strength over different horizons
6M Return
111.0%
12M Return
97.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
24.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.28
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-29.2%
Earnings Stability (CV)
Lower = more stable
0.142
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
3
Dividend Yield
0.0%
Buyback Yield
-24.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity